Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Lymphoid Malignancies in Shwachman-Diamond Syndrome

Helen D. Reed, Hyunwoo Do, Edie A. Weller, Marian H. Harris, Jason E. Farrar, Bonnie W. Lau, Lauren Pommert, Christopher Gamper, Ian Atkinson, Katherine Coyne, Margret Joos, Sara Loveless, Sarah Steltz, Leah Cheng, Maggie Malsch, Kasiani Myers, Akiko Shimamura

Blood (2024) 144 (Supplement 1): 5707.

https://doi.org/10.1182/blood-2024-200116

Published: 2024

Journal Articles

Multivariable Analyses of Prognostic Factors for Progression-Free Survival (PFS) and Complete Response (CR) with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial

Blood (2022) 140 (Supplement 1): 4834–4838.

https://doi.org/10.1182/blood-2022-162741

Published: 2022

Journal Articles

Metformin for Treatment of Cytopenias in Children and Young Adults with Fanconi Anemia

Blood (2021) 138 (Supplement 1): 1102.

https://doi.org/10.1182/blood-2021-153598

Published: 2021

Journal Articles

Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome

Alyssa L. Kennedy, MDPhD, Kasiani C. Myers, MD, James Bowman, PhD, Christopher J. Gibson, MD, Gwen M. Muscato, Robert Klein, Kaitlyn Ballotti, Nicholas Camarda, Elissa M. Furutani, MD, Chad E. Harris, MS, Shanshan Liu, PhD, Ashley Galvin, Maggie Malsch, MSN, RN, David C. Dale, MD, John M Gansner, MD PhD, Taizo A. Nakano, MD, Alison A. Bertuch, MD, Adrianna Vlachos, MD, Jeff H. Lipton, MD PhD, Paul Castillo, MD, James Connelly, John Edwards, MD, Nobuko Hijiya, MD, Richard Ho, MD, Inga Hofmann, MD, James N Huang, MD, Sioban B. Keel, MD, Adam J. Lamble, MD, Bonnie W Lau, MD PhD, Kelly J. Walkovich, MD, Maxim Norkin, MD, Wendy Stock, MD, Steffen Boettcher, Christian Brendel, PhD, Elliot Stieglitz, MD, Mark D. Fleming, MD DPhil, Stella M. Davies, PhD MBBS, MRCP, Edie A. Weller, Chris Bahl, PhD, Scott L. Carter, PhD, Akiko Shimamura, MD PhD, R. Coleman Lindsley, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-137125

Published: 2020

Journal Articles

Outcomes of Immunosuppressive Therapy for Pediatric Aplastic Anemia: A North American Pediatric Aplastic Anemia Consortium (NAPAAC) Study

Blood (2017) 130 (Supplement 1): 1168.

https://doi.org/10.1182/blood.V130.Suppl_1.1168.1168

Published: 2017

Journal Articles

Circulating Exosomal microRNAs Are Prognostic Markers in Multiple Myeloma

Salomon Manier, MD, Herve Avet-Loiseau, Federico Campigotto, MS, Karma Salem, MD, Daisy Huynh, BS, MS, Siobhan Glavey, MD, Antonio Sacco, BS, Aldo M Roccaro, MD PhD, Stephane Minvielle, Philippe Moreau, MD PhD, Thierry Facon, Xavier Leleu, MD PhD, Edie A. Weller, PhD, Irene M. Ghobrial, MD

Blood (2015) 126 (23): 1770.

https://doi.org/10.1182/blood.V126.23.1770.1770

Published: 2015

Journal Articles

Phase 1 Dose-Escalation Study of Sotatercept (ACE-011) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Andrew J. Yee, MD, Jacob P. Laubach, MD, Ajay K. Nooka, MD MPH, Elizabeth K. O'Donnell, MD, Edie A. Weller, PhD, Nicole R. Couture, BSN, RN, Ellen E. Wallace, BA, Jill N. Burke, NP, Cynthia C. Harrington, NP, Marie Puccio-Pick, MS, Abderrahmane Laadem, MD, Matthew L. Sherman, MD, Noopur S. Raje, MD

Blood (2015) 126 (23): 4241.

https://doi.org/10.1182/blood.V126.23.4241.4241

Published: 2015

Journal Articles

Prognostic Value of Circulating Exosomal microRNAs in 112 Patients with Multiple Myeloma

Salomon Manier, MD, Herve Avet-Loiseau, Federico Campigotto, MS, Siobhan Glavey, MD, Karma Salem, MD, Daisy Huynh, MPS, Erica N Boswell, BS, Antonio Sacco, BS, Yuji Mishima, PhD, Michele Moschetta, MD, Michaela R. Reagan, PhD, Yawara Kawano, MDPhD, Kenneth C. Anderson, MD, Aldo M Roccaro, MD PhD, Philippe Moreau, MD, Thierry Facon, MD, Xavier Leleu, MD PhD, Edie A. Weller, PhD, Irene M. Ghobrial, MD

Blood (2014) 124 (21): 2056.

https://doi.org/10.1182/blood.V124.21.2056.2056

Published: 2014

Journal Articles

Final Results of Phase I/II Trial of the Oral mTOR Inhibitor Everolimus (RAD001) in Combination with Bortezomib and Rituximab (RVR) in Relapsed or Refractory Waldenstrom Macroglobulinemia

Irene M. Ghobrial, MD, Robert Allyn Redd, MS, Jeffrey Matous, Philippe Armand, MD PhD, Erica N Boswell, BS, Stacey Chuma, BSN, Kimberly Noonan, RN, NP, AOCN, Megan H. MacNabb, BA, Ranjit Banwait, Courtney Hanlon, Houry Leblebjian, PharmD, BCOP, Diane Warren, Jorge J. Castillo, MD, Jacob P. Laubach, MD, Claudia E. Paba-Prada, MD, Kenneth C. Anderson, MD, Paul G. Richardson, Edie A. Weller, PhD, Steven P Treon, MD MA, PhD

Blood (2014) 124 (21): 3081.

https://doi.org/10.1182/blood.V124.21.3081.3081

Published: 2014

Journal Articles

Time to Development of Treatment-Emergent Extramedullary and Osseous Plasmacytomas in the Era of Novel Agents: An Analysis of Upfront Regimens in Newly Diagnosed MM Incorporating Lenalidomide and Bortezomib

Cindy Varga, Jacob P. Laubach, MD, Irene M. Ghobrial, MD, Matthew Weinstock, MD, Claudia E. Paba-Prada, MD, Robert L. Schlossman, MD, Nikhil Munshi, Wanling Xie, MS, Edie A. Weller, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD PhD, Paul G. Richardson

Blood (2014) 124 (21): 3468.

https://doi.org/10.1182/blood.V124.21.3468.3468

Published: 2014

Journal Articles

Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution

Houry Leblebjian, PharmD, BCOP, Wanling Xie, MS, Paul G. Richardson, MD, Irene M. Ghobrial, MD, Christy Harris, PharmD, BCPS, BCOP, Robert L Schlossman, MD, Claudia E. Paba-Prada, MD, Nikhil C. Munshi, MD, Sylvia Bartel, R.Ph., M.H.P., Kenneth C. Anderson, MD, Edie A. Weller, PhD, Jacob P. Laubach, MD

Blood (2013) 122 (21): 1977.

https://doi.org/10.1182/blood.V122.21.1977.1977

Published: 2013

Journal Articles

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Yosra Aljawai, MS, Serena McDiarmid, Joseph Cappuccio, Federico Campigotto, MS, Steven Peter Treon, MD, MA, PhD, Edie A. Weller, PhD, Brenda M. Birmann, ScD, Irene M Ghobrial, MD

Blood (2013) 122 (21): 1713.

https://doi.org/10.1182/blood.V122.21.1713.1713

Published: 2013

Journal Articles

Improved Risk Stratification With Addition Of Male Sex (S) To The Elderly International Prognostic Index (S-EIPI) For DLBCL Patients > 60 Years Treated With R-CHOP: An International Collaboration Of The US Intergroup, German High-Grade Non-Hodgkin Lymphoma Study Group and Groupe d’Etude De Lymphome d’Adultes

Ranjana H. Advani, MD, Fangxin Hong, PhD, Thomas M. Habermann, MD, Hailun Li, MS, Brad S. Kahl, MD, Vicki A. Morrison, MD, Edie A. Weller, PhD, Gaurav Varma, MSPH, Richard I Fisher, MD, Bruce A. Peterson, MD, Bruce D. Cheson, M.D., Randy D. Gascoyne, MD, Sandra J. Horning, MD, Sami Bousetta, Bertrand Coiffier, MD, PhD, Marita Ziepert, Michael Pfreundschuh, MD

Blood (2013) 122 (21): 3045.

https://doi.org/10.1182/blood.V122.21.3045.3045

Published: 2013

Journal Articles

Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab

Thomas M Habermann, MD, Fangxin Hong, PhD, Vicki A. Morrison, MD, Shaker R. Dakhil, MD, James K. Weick, MD, Stanley R. Frankel, MD, Randy D. Gascoyne, MD, Richard I Fisher, MD, Bruce D. Cheson, MD, Edie A. Weller, PhD, Brad S. Kahl, M.D., Bruce A. Peterson, MD, Howard S Hochster, MD, Sandra J. Horning, M.D.

Blood (2012) 120 (21): 3705.

https://doi.org/10.1182/blood.V120.21.3705.3705

Published: 2012

Journal Articles

Biomarker Correlation with Outcomes in Patients with Relapsed or Refractory Multiple Myeloma on a Phase I Study of Everolimus in Combination with Lenalidomide,

Andrew J. Yee, MD, Anuj K. Mahindra, MD, Paul G. Richardson, MD, Diana D. Cirstea, MD, Tyler A. Scullen, BA, Scott J. Rodig, MD, PhD, Teru Hideshima, MD, PhD, Parameswaran Hari, MBBS, MD, MRCP, Jacob P. Laubach, MD, Irene M. Ghobrial, MD, Robert Schlossman, MD, Nikhil C. Munshi, MD, Edie A. Weller, PhD, Kenneth C. Anderson, MD, Noopur S. Raje, MD

Blood (2011) 118 (21): 3966.

https://doi.org/10.1182/blood.V118.21.3966.3966

Published: 2011

Journal Articles

Response: Outcomes with R-CHOP in DLBCL leave ample room for improvement

Jane N. Winter, Edie A. Weller, Sandra J. Horning, Randy D. Gascoyne

Blood (2007) 109 (2): 844.

https://doi.org/10.1182/blood-2006-09-044297

Published: 2007

Journal Articles

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Jane N. Winter, Edie A. Weller, Sandra J. Horning, Maryla Krajewska, Daina Variakojis, Thomas M. Habermann, Richard I. Fisher, Paul J. Kurtin, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, John C. Reed, Randy D. Gascoyne

Blood (2006) 107 (11): 4207–4213.

https://doi.org/10.1182/blood-2005-10-4222

Published: 2006

Journal Articles

Patterns of Growth Factor (GF) Usage and Febrile Neutropenia (FN) among Older Patients (pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP or R-CHOP: An Intergroup Experience (CALGB 9793, ECOG-SWOG 4494).

Vicki A. Morrison, MD, Edie A. Weller, PhD, Thomas M. Habermann, MD, Shuli Li, MS, Sandra J. Horning, MD, Richard I. Fisher, MD, Bruce A. Peterson, MD

Blood (2004) 104 (11): 3309.

https://doi.org/10.1182/blood.V104.11.3309.3309

Published: 2004

NARROW

Lymphoid Malignancies in Shwachman-Diamond Syndrome

Metformin for Treatment of Cytopenias in Children and Young Adults with Fanconi Anemia

Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome

Outcomes of Immunosuppressive Therapy for Pediatric Aplastic Anemia: A North American Pediatric Aplastic Anemia Consortium (NAPAAC) Study

Circulating Exosomal microRNAs Are Prognostic Markers in Multiple Myeloma

Phase 1 Dose-Escalation Study of Sotatercept (ACE-011) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Prognostic Value of Circulating Exosomal microRNAs in 112 Patients with Multiple Myeloma

Final Results of Phase I/II Trial of the Oral mTOR Inhibitor Everolimus (RAD001) in Combination with Bortezomib and Rituximab (RVR) in Relapsed or Refractory Waldenstrom Macroglobulinemia

Time to Development of Treatment-Emergent Extramedullary and Osseous Plasmacytomas in the Era of Novel Agents: An Analysis of Upfront Regimens in Newly Diagnosed MM Incorporating Lenalidomide and Bortezomib

Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab

Biomarker Correlation with Outcomes in Patients with Relapsed or Refractory Multiple Myeloma on a Phase I Study of Everolimus in Combination with Lenalidomide,

Response: Outcomes with R-CHOP in DLBCL leave ample room for improvement

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Patterns of Growth Factor (GF) Usage and Febrile Neutropenia (FN) among Older Patients (pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP or R-CHOP: An Intergroup Experience (CALGB 9793, ECOG-SWOG 4494).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only